Generate Biomedicines (GENB) EV/EBIT: History & Chart

Generate Biomedicines, Inc.(GENB)

Biotechnology · Somerville, MA

$13.80-0.11 (-0.79%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Generate Biomedicines, Inc.

Generate Biomedicines, Inc. is a U.S.-based company pioneering generative biology, leveraging machine learning for the discovery and advancement of novel protein therapeutics. Their core approach involves developing drugs using protein-based modalities. The company's pipeline includes several key candidates: GB-0895, an investigational long-acting anti-TSLP monoclonal antibody designed for bi-annual dosing in severe asthma; GB-4362, an MMAE payload neutralizer monoclonal antibody; and GB-5267, a MUC16 CAR-T cell therapy. Integral to their work is the Generate Platform, a sophisticated system engineered to be versatile across diverse therapeutic areas and protein modalities. This platform combines computational innovation with scalable biohardware, allowing them to tackle therapeutic hurdles beyond the capabilities of traditional technologies. Established in 2018, the company was initially known as Generate Biologics, Inc. before rebranding to Generate Biomedicines, Inc. in February 2020. Its headquarters are located in Somerville, Massachusetts.

Somerville, MA

312 employees

generatebiomedicines.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Michael T. Nally

View full financials

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Generate Biomedicines, Inc. (GENB)	$1.77B	N/A	N/A	N/A	N/A
Surgery Partners, Inc. (SGRY)vs ›	$1.75B	13.87x	14.36x	17.64x	18.88x
Novocure Ltd (NVCR)vs ›	$1.74B	N/A	783.33x	1393.80x	1393.80x
Absci Corporation (ABSI)vs ›	$1.74B	N/A	N/A	N/A	N/A
Xeris Biopharma Holdings, Inc. (XERS)vs ›	$1.74B	52.09x	67.78x	67.78x	67.78x
Alignment Healthcare, Inc. (ALHC)vs ›	$1.74B	24.97x	614.86x	614.86x	614.86x
Xencor, Inc. (XNCR)vs ›	$1.81B	N/A	30.48x	45.80x	56.24x
LeMaitre Vascular, Inc. (LMAT)vs ›	$1.81B	25.48x	35.10x	39.10x	37.80x
Intellia Therapeutics, Inc. (NTLA)vs ›	$1.73B	N/A	N/A	N/A	N/A
Azenta, Inc. (AZTA)vs ›	$1.81B	N/A	227.18x	114.14x	99.57x

NAME

MARKET CAP

EV/EBIT RATIO

TTM

Generate Biomedicines, Inc. (GENB)

$1.77B

N/A

Surgery Partners, Inc. (SGRY)vs ›

$1.75B

13.87x

14.36x

17.64x